SemBioSys
Genetics, Inc.
#110, 2985 - 23rd
Avenue
N.E.Calgary, AB T1Y7L3
Canada
E-mail:
info@sembiosys.com
Tel: +1
(403) 250-5424
Fax: +1
(403) 250-3886
Web site: www.sembiosys.ca |
|
SemBioSys
Genetics Inc. is
a privately held biotechnology company focused on the development of
high-value protein and oilbody-based products using its proprietary
oilbody-based technology - the Stratosome™ Biologics System. Spun out of
the University of Calgary in 1996, the company’s investors include Bay
City Capital, Dow AgroSciences Canada, Inc., Ventures West Management
Inc., BDC Venture Capital, University Technologies International Inc.,
RBC Capital Partners and Maurice Moloney Ph.D. scientific founder and
chief scientific officer. In addition to these investors, SemBioSys has
received repayable contributions of CAD$5.5MM from Technology
Partnerships Canada, an agency of Industry Canada, and CAD$4.9MM from
AVAC Ltd. |
|
|
